NANCY PALMER: Open Payments
NPI 1659430866 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$158 in 7 payments from 5 companies in 2025. Trend: 2023 $28 · 2024 $138 · 2025 $158
Food & beverage: $158
| Company | Payments | Amount |
|---|---|---|
| Tanabe Pharma America, Inc. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Alexion Pharmaceuticals, Inc. | 1 | $34 |
| Genentech USA, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: Radicava, WAINUA, ULTOMIRIS, Evrysdi, ENTYVIO.
Industry payments across CA — which companies pay providers there.
